Board approved a rights issue of 9.58 lakh fully paid equity shares at Rs 950 per share, aggregating Rs 91.0 Cr, in a 97:1,831 ratio. Record date is September 2, 2026; issue opens September 9 and closes September 22, 2026. This is a sizable follow-on equity raise shortly after the IPO and breaks the company’s prior no-dilution pattern. The filing does not disclose the intended use of proceeds. Post-issue shares would increase to 1.90 Cr from 1.81 Cr, implying approximately 5.3% dilution for non-participating shareholders. Promoter participation and other detailed issue terms remain undisclosed.
Anondita Medicare Named L1 Bidder For CMSS 800.62 Million-Unit Tender
Anondita Medicare Files ₹91.01 Crore Rights Issue Letter Of Offer
Anondita Medicare Receives NSE In-Principle Approval For ₹109.782 Crore Rights Issue